NCT04232514View on ClinicalTrials.gov

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 22, 2020

Conditions
Chronic Hepatitis C
Interventions
DRUG

HEC74647

Administered HEC74647 200 mg orally once daily in fed state

DRUG

HEC110114

Administered HEC110114 800 mg orally once daily in fed state

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT04232514 - Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter